Skip to content

Intraoperative Pathway in DIEP Flap Breast Reconstruction

Intraoperative Pathway in DIEP Flap Breast Reconstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00543764
Enrollment
150
Registered
2007-10-15
Start date
2005-01-31
Completion date
2011-02-28
Last updated
2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Intraoperative Pathway, Breast Reconstruction, DIEP flap

Brief summary

Efficiency in the operating room can be difficult in long cases with multiple surgeons. We used a team based approach to develop an intraoperative pathway for microsurgical breast reconstruction with a deep inferior epigastric perforator flap.

Detailed description

A team based approach was developed with an intraoperative pathway for microsurgical breast reconstruction with a deep inferior epigastric perforator flap.

Interventions

OTHERpathway

Comparison of pre and post pathway

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* All cases prior to pathway

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Operative Time3 yearsLength of Time in surgery

Countries

United States

Participant flow

Recruitment details

2006-2008. Operating room records

Participants by arm

ArmCount
Pre Pathway
Patients prior to pathway implementation
100
Post Pathway
Patients after pathway implementation
50
Total150

Baseline characteristics

CharacteristicPre PathwayPost PathwayTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
100 Participants50 Participants150 Participants
Sex/Gender, Customized
Female
100 paticipants50 paticipants150 paticipants
Sex/Gender, Customized
Male
0 paticipants0 paticipants0 paticipants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1000 / 50
serious
Total, serious adverse events
0 / 1000 / 50

Outcome results

Primary

Operative Time

Length of Time in surgery

Time frame: 3 years

ArmMeasureValue (MEAN)
Pre PathwayOperative Time8.2 hours
Post PathwayOperative Time6.9 hours

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026